Drug Type Small molecule drug |
Synonyms Gemifloxacin, Gemifloxacin mesylate (USAN), ARB-FV0127 + [9] |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors), quinolone antibiotics |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (04 Apr 2003), |
Regulation- |
Molecular FormulaC19H24FN5O7S |
InChIKeyJIYMVSQRGZEYAX-CWUUNJJBSA-N |
CAS Registry210353-53-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02471 | Gemifloxacin Mesylate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Otitis Media | South Korea | 10 Nov 2014 | |
| Respiratory Tract Infections | China | 18 Oct 2014 | |
| Urinary Tract Infections | Mexico | 28 Nov 2008 | |
| Sinusitis | Mexico | 29 Sep 2006 | |
| Bacterial Infections | South Korea | 04 Apr 2003 | |
| Bronchitis, Chronic | United States | 04 Apr 2003 | |
| Community Acquired Pneumonia | United States | 04 Apr 2003 | |
| Infectious Diseases | United States | 04 Apr 2003 |





